Keurig Dr Pepper Inc. · KDP · FY2026 Q1 · Calendar Q2 2026
KDP Beats on Q1 EPS and Revenue as Refreshment Strength Offsets Coffee Headwinds
Keurig Dr Pepper delivered a solid Q1 beat with net sales up 8% and EPS of $0.39 versus $0.37 consensus, powered by U.S. refreshment beverage strength. The company closed its transformative JDE Peet's acquisition on April 1, 2026, and reaffirmed its low-double-digit EPS growth outlook for 2026. Near-term coffee cost headwinds and trade inventory adjustments pressured the coffee segment, but management expects profitability improvement in the second half. The stock responded with an approximately 7.5% move on the report. The planned separation into Beverage Co. and Global Coffee Co. is targeted for early 2027, with $2.5B in projected free cash flow for 2026 supporting deleveraging from the roughly 4.5x leverage position.
Company context
Snapshot as of publicationKeurig Dr Pepper Inc. is a prominent beverage firm with operations spanning both the United States and global markets. The company structures its business across four primary divisions: Coffee Systems, Packaged Beverages, Beverage Concentrates, and Latin America Beverages. Its Coffee Systems division is responsible for the production and distribution of an array of finished products linked to its coffee brewing systems, including K-Cup single-serve pods, brewing machines, and specialized coffee blends. Brewers are offered for sale via external distributors, various retail outlets, and directly through its official website, keurig.com. The Packaged Beverages segment focuses on manufacturing and distributing its proprietary packaged drink labels.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Overweight | Maintain | Jul 23, 2026 |
| UBS | Buy | Buy | Maintain | Jul 16, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 14, 2026 |
| Barclays | Overweight | Equal Weight | Upgrade | Jun 25, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Apr 24, 2026 |
| BNP Paribas | Neutral | Underperform | Upgrade | Apr 22, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 8, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 30, 2026 |
| Jefferies | Hold | Buy | Downgrade | Dec 17, 2025 |
| Piper Sandler | Overweight | Overweight | Maintain | Dec 15, 2025 |
| B of A Securities | Buy | Buy | Maintain | Oct 8, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 2, 2025 |
| HSBC | Hold | Buy | Downgrade | Aug 26, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 22, 2025 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Apr 1, 2025 |
| TD Cowen | Hold | Hold | Maintain | Jan 8, 2025 |
| Truist Securities | Hold | Sell | Upgrade | Jun 17, 2024 |
| Wedbush | Outperform | Outperform | Maintain | Feb 26, 2024 |
| Bernstein | Outperform | Outperform | Maintain | Oct 12, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 30, 2021 |
| Bank of America | Buy | Buy | Maintain | Aug 9, 2019 |
| BMO Capital | Outperform | Market Perform | Upgrade | Jun 17, 2019 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Dec 7, 2018 |
| Macquarie | Outperform | Outperform | Maintain | Dec 4, 2018 |
| Gabelli & Co. | Hold | Buy | Downgrade | Nov 9, 2018 |
| Guggenheim | Neutral | Neutral | Maintain | Sep 14, 2018 |
| Susquehanna | Outperform | Positive | Maintain | Jul 25, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 11, 2018 |
Named analyst price targets
Upside is calculated against the persisted current price $31.45. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Peter Grom | $38 | $31.05 | +20.8% | Jul 16, 2026 |
| Bernstein | Analyst unavailable | $39 | $31.24 | +24.0% | Jul 8, 2026 |
| Wells Fargo | Analyst unavailable | $37 | $32.73 | +17.6% | Jul 1, 2026 |
| Bernstein | Analyst unavailable | $38 | $31.23 | +20.8% | Jun 11, 2026 |
| UBS | Analyst unavailable | $34 | $28.85 | +8.1% | Apr 24, 2026 |
| Evercore ISI | Analyst unavailable | $30 | $28.76 | -4.6% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $28 | $25.93 | -11.0% | Apr 14, 2026 |
| UBS | Peter Grom | $36 | $30.49 | +14.5% | Feb 26, 2026 |
| Jefferies | Kaumil Gajrawala | $32 | $28.59 | +1.7% | Dec 16, 2025 |
| Piper Sandler | Michael Lavery | $38 | $29.5 | +20.8% | Dec 15, 2025 |
| Deutsche Bank | Analyst unavailable | $32 | $29.5 | +1.7% | Dec 15, 2025 |
| UBS | Peter Grom | $35 | $28.69 | +11.3% | Oct 28, 2025 |
| Barclays | Lauren Lieberman | $30 | $28.64 | -4.6% | Oct 28, 2025 |
| Wells Fargo | Analyst unavailable | $35 | $28.68 | +11.3% | Oct 28, 2025 |
| BNP Paribas | Kevin Grundy | $24 | $27.11 | -23.7% | Sep 22, 2025 |
| HSBC | Sorabh Daga | $30 | $30.48 | -4.6% | Aug 26, 2025 |
| Jefferies | Kaumil Gajrawala | $41 | $31.1 | +30.4% | Aug 25, 2025 |
| HSBC | Analyst unavailable | $42 | $34.4 | +33.5% | Apr 25, 2025 |
| Barclays | Analyst unavailable | $39 | $34.2 | +24.0% | Feb 27, 2025 |
| Piper Sandler | Mike Lavery | $35 | $34.12 | +11.3% | Feb 25, 2025 |
| Jefferies | Kaumil Gajrawala | $42 | $36.92 | +33.5% | Oct 16, 2024 |
| Barclays | Lauren Lieberman | $41 | $36.51 | +30.4% | Oct 11, 2024 |
| Deutsche Bank | Steve Powers | $37 | $37.46 | +17.6% | Sep 23, 2024 |
| Citigroup | Filippo Falorni | $43 | $37.46 | +36.7% | Sep 23, 2024 |
| Barclays | Lauren Lieberman | $37 | $33.14 | +17.6% | Jul 19, 2024 |
| Truist Financial | Bill Chappell | $34 | $34.06 | +8.1% | Jun 17, 2024 |
| UBS | Sean King | $40 | $34.22 | +27.2% | Jun 10, 2024 |
| Wells Fargo | Bonnie Herzog | $41 | $34.82 | +30.4% | Jun 5, 2024 |
| Jefferies | Kaumil Gajrawala | $39 | $33.84 | +24.0% | Apr 25, 2024 |
| Jefferies | Kaumil Gajrawala | $35 | $30.73 | +11.3% | Mar 27, 2024 |
| Credit Suisse | Theo Brito | $38 | $35 | +20.8% | Mar 21, 2023 |
| Wells Fargo | Analyst unavailable | $40 | $35.34 | +27.2% | Jan 3, 2023 |
| Deutsche Bank | Analyst unavailable | $39 | $37.76 | +24.0% | Dec 6, 2022 |
| Deutsche Bank | Steve Powers | $38 | $38.11 | +20.8% | Oct 28, 2022 |
| Goldman Sachs | Bonnie Herzog | $37 | $37.28 | +17.6% | Sep 27, 2022 |
| Barclays | Analyst unavailable | $46 | $37.8 | +46.3% | May 2, 2022 |
| RBC Capital | Analyst unavailable | $43 | $37.99 | +36.7% | Apr 29, 2022 |
| UBS | Sean King | $41 | $34.67 | +30.4% | Jul 30, 2021 |
| Morgan Stanley | Dara Mohsenian | $36 | $35.11 | +14.5% | Apr 30, 2021 |
Track every rating change on KDP the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session closeFollow KDP with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
KDP reported Q1 FY2026 net sales of $3.98B versus $3.84B consensus (a 3.7% surprise) and EPS of $0.39 versus $0.37 consensus (a 4.7% surprise). Net sales grew 8% year over year, led by U.S. refreshment beverages. EPS declined from the prior year due to cost pressures and a lapped prior-year gain but still exceeded estimates. The JDE Peet's acquisition closed on April 1, 2026, with the full financing package of $4.5B convertible preferred equity, $4B pod-manufacturing JV minority investment, and $6B senior debt completed. The stock moved approximately 7.5% higher on the report, with volume at 1.86x the baseline. The company generated $184M of free cash flow in Q1 and raised its 2026 aggregate free cash flow projection to $2.5B from the prior $2B figure to reflect JDE Peet's contributions.
Guidance delta
Management reaffirmed its low-double-digit EPS growth outlook for 2026, maintaining the guidance stance from the prior quarter. The free cash flow projection was raised to $2.5B aggregate for 2026 (from $2B previously), now reflecting JDE Peet's contributions. The separation timeline into Beverage Co. and Global Coffee Co. remains targeted for early 2027, unchanged from prior commentary.
Key takeaways
- Q1 net sales grew 8% year over year to $3.98B, beating consensus by 3.7%, driven by strength in U.S. refreshment beverages.
- EPS of $0.39 exceeded the $0.37 consensus by 4.7%, though it declined from the prior year due to cost pressures and a lapped prior-year gain.
- The JDE Peet's acquisition closed on April 1, 2026, with the full financing package of $4.5B convertible preferred equity, $4B pod-manufacturing JV minority investment, and $6B senior debt completed.
- Management reaffirmed low-double-digit EPS growth guidance for 2026 and raised the free cash flow projection to $2.5B (from $2B) including JDE Peet's contributions.
- The coffee segment faces near-term green coffee cost headwinds and trade inventory adjustments, but management expects profitability improvement in the second half of 2026.
- The innovation pipeline includes the Keurig Alta direct-to-consumer coffee system launch later in 2026, alongside new CSDs, energy drinks, and expanded partnership distribution.
Management priorities
- Complete operational integration of JDE Peet's and prepare for the 2027 separation into Beverage Co. and Global Coffee Co.
- Launch the Keurig Alta system directly to consumers later in 2026.
- Expand the coffee partnership with Nestle USA and roll out new Keurig Coffee Collective innovations.
- Increase marketing spend and precision-marketing capabilities across brands.
- Explore non-core asset divestitures and minority investment sales to accelerate deleveraging from approximately 4.5x leverage.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-30T04:21:51.415319+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T04:21:51.412328+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.